Contact
Please use this form to send email to PR contact of this press release:
Esperion Therapeutics Announces Initiation of Phase 3 Clinical Program With Long-Term Safety and Tolerability Study
TO:
Please use this form to send email to PR contact of this press release:
Esperion Therapeutics Announces Initiation of Phase 3 Clinical Program With Long-Term Safety and Tolerability Study
TO: